Bladder cancer treatment success

Israel’s Biocancell Therapeutics Ltd has reported success in the Phase IIb clinical trial of BC-819 for the treatment of bladder cancer in patients for whom chemotherapy or standard treatment using Bacillus Calmette-Guerin (BCG) failed.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *